When.com Web Search

  1. Ads

    related to: anticholinergic medication for overactive bladder

Search results

  1. Results From The WOW.Com Content Network
  2. Oxybutynin - Wikipedia

    en.wikipedia.org/wiki/Oxybutynin

    Oxybutynin, sold under the brand name Ditropan among others, is an anticholinergic medication primarily used to treat overactive bladder.It is widely considered a first-line therapy for overactive bladder due to its well-studied side effect profile, broad applicability, and continued efficacy over long periods of time.

  3. Solifenacin - Wikipedia

    en.wikipedia.org/wiki/Solifenacin

    Solifenacin, sold as the brand name Vesicare [a] among others, is a medicine used to treat overactive bladder and neurogenic detrusor overactivity (NDO). [1] [2] It may help with incontinence, urinary frequency, and urinary urgency. [3] Benefits appear similar to other medications in the class. [4] It is taken by mouth. [1]

  4. Mirabegron - Wikipedia

    en.wikipedia.org/wiki/Mirabegron

    Mirabegron is the first clinically available beta-3 agonist with approval for use in adults with overactive bladder. Mirabegron was approved for medical use in the United States and in the European Union in 2012. [8] [9] [3] In 2022, it was the 222nd most commonly prescribed medication in the United States, with more than 1 million prescriptions.

  5. 14 Overactive Bladder Treatments Doctors Recommend - AOL

    www.aol.com/14-overactive-bladder-treatments...

    Overactive bladder isn’t a disease but rather a syndrome defined by a collection of symptoms, says Jennifer Linehan, MD, a urologist and associate professor of urologic oncology at the John ...

  6. Merck Gains FDA Approval for First OTC Patch for Overactive ...

    www.aol.com/2013/01/25/merck-gains-fda-approval...

    The FDA has approved Merck's Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women, a condition that Merck says affects more than 20 million American women.

  7. Darifenacin - Wikipedia

    en.wikipedia.org/wiki/Darifenacin

    Darifenacin (trade name Enablex in United States and Canada, Emselex in the European Union) is a medication used to treat urinary incontinence due to an overactive bladder. [1] [2] [3] It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis.

  1. Ad

    related to: anticholinergic medication for overactive bladder